BD Launches Fully Automated, High-Throughput Disease Molecular Diagnostic Platform
BD announced the U.S. launch of its new, fully automated, high-throughput infectious disease molecular diagnostics platform.
Read MorePosted by Andy Lundin | May 12, 2022 | Infectious Diseases, Molecular Diagnostic Analyzers |
BD announced the U.S. launch of its new, fully automated, high-throughput infectious disease molecular diagnostics platform.
Read MorePosted by Chris Wolski | May 12, 2022 | Sepsis |
Improving outcomes with sepsis is dependent on timely diagnosis and treatment. Culture-independent testing is one way to save time.
Read MorePosted by Andy Lundin | May 11, 2022 | Colorectal |
Freenome completed the enrollment for PREEMPT CRC, a large, prospective study to validate its blood test for colorectal cancer screening.
Read MorePosted by Andy Lundin | May 10, 2022 | Covid 19, Immunoassay Reagents & test Kits |
Revival Health was awarded as the exclusive distributor of Xiamen Boson Biotech’s Rapid SARS-CoV-2 Antigen Tests following a joint agreement.
Read MorePosted by Chris Wolski | May 10, 2022 | Urine Analyzers |
Researchers have developed a smart diaper that measures multiple components in urine and can share those results over Bluetooth.
Read More